Fosun Pharma's PharmAID Launch, Mitsubishi's AI Drug Discovery, and FIG's Nutraceutical Investment - Life AI Weekly #5

Hi there,

In this edition of Life AI Weekly, we're diving into the latest advancements in healthcare and life sciences AI. FIG has made a strategic investment in Elitepharm to enhance AI applications in nutraceuticals, while Mitsubishi and its partners have successfully demonstrated a remote GPU solution aimed at accelerating AI-driven drug discovery. Meanwhile, Fosun Pharma has launched the PharmAID platform, which is set to revolutionize the pharmaceutical industry with its AI capabilities.

On the research front, Exactech has unveiled new AI and polyethylene research at a recent meeting, and a new AI tool called RECTIFIER is enhancing heart failure trial enrollment. Additionally, researchers have developed an AI system to interpret animal emotions, potentially opening new avenues in veterinary care and animal welfare. Stay tuned as we explore these exciting developments and more in the world of AI in healthcare and life sciences.

Keragon, a New York-based AI healthcare automation platform, has secured $7.5 million in seed funding led by Upfront Ventures, increasing its total funding to $10.5 million. A new bill introduced by Representative David Schweikert aims to allow AI models to prescribe FDA-approved drugs by recognizing them as health practitioners. Ecrio and Inventec have announced a partnership to enhance critical communication solutions for Edge AI applications, aiming to improve safety and efficiency in various industries. Ping An Healthcare and Technology Company Limited has integrated the DeepSeek AI model into its systems to enhance medical services and disease diagnosis capabilities. Abridge has raised $250 million in Series D funding to enhance its generative AI platform for clinical conversations. The investment will aid in developing a new Contextual Reasoning Engine to improve clinical documentation and billing, with deployment in over 100 U.S. health systems. HiLabs has been recognized in a Gartner report for its role in advancing Generative AI solutions for U.S. healthcare payers, focusing on optimizing administrative functions and improving patient outcomes. Fangzhou Inc. has announced the integration of the DeepSeek-R1 open-source AI model to enhance its Internet healthcare services in Shanghai. This initiative aims to improve service capabilities and operational efficiency, with plans for specialized 'AI Agent' applications in 2025.

Freedom International Group has invested in Elitepharm Laboratoires to enhance AI technology in dietary supplements, aiming for significant revenue growth by 2029. A collaboration between Mitsubishi, NTT, NTT Com, Morgenrot, and iPark Institute has launched a demonstration in Japan to provide remote GPU computing for AI drug discovery, aiming to improve research efficiency and security. Fosun Pharma has launched the PharmAID decision intelligence platform to enhance AI integration in drug research and development. On February 11, 2025, Everest Group recognized Indegene for its leadership in generative AI within the life sciences sector. Researchers at Shandong University have developed a generative AI model to create diverse antimicrobial peptide structures, aiming to combat antibiotic resistance.

Exactech presented 15 new studies at the 2025 Orthopaedic Research Society Annual Meeting, highlighting advancements in joint arthroplasty and trauma solutions using AI and machine learning. Researchers at Mass General Brigham have developed an AI tool called RECTIFIER that significantly increases the efficiency of patient enrollment in heart failure clinical trials, nearly doubling the enrollment rate compared to manual methods. Researchers are advancing AI systems to understand animal emotions, with a focus on detecting pain and distress in animals like pigs, dogs, and horses. The Intellipig system analyzes pig facial expressions, while other teams work on recognizing discomfort in dogs and horses.

Latent Labs, founded by former DeepMind scientist Simon Kohl, has secured $50 million to focus on AI-driven protein design. Saudi Arabia has teamed up with Paradromics to develop brain-computer interface implants for the Neom project. Larry Ellison, co-founder of Oracle, suggests consolidating all US data into a single AI system.

URAC has announced the creation of a Health Care AI Accreditation to promote safe and ethical AI use in health care. Infinx Healthcare is set to unveil its Revenue Cycle Agent Platform and Document Capture AI Platform at ViVE 2025 in Nashville. The Centre for Responsible AI (CeRAI) at IIT Madras has teamed up with a global leader in in-vitro diagnostics to advance ethical AI solutions in healthcare.